Home / Stock ratings / THC
Stock rating · Services-General Medical & Surgical Hospitals, Nec
Tenet Healthcare Corporation New (THC) Stock Rating & Analysis
As of October 9, 2026, MELANY rates Tenet Healthcare Corporation New 76 out of 100 (Highest Conviction). Its highest factor scores are earnings track record and catalyst setup at 92, and its lowest is macro fit at 50.
MELANY ratingRated 2026-10-09THC · composite score
About Tenet Healthcare Corporation New
Tenet Healthcare is a Dallas-based healthcare services company that operates acute and specialty hospitals (50 as of December 2025) along with hundreds of ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, it also provides revenue cycle management solutions.
Rating as of 2026-10-09 · this is a dated snapshot; the live rating is in the app (Pro, free for 30 days). The price above updates in real time.
Why THC scores 76/100
THC's 8 factor scores run from 50 to 92, and 2 of them sit above its composite of 76. Here is how THC breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- P/E 10.3x vs sector 22.0x median
- FCF yield 10.5%
Margins, returns on capital, and balance-sheet strength.
- Gross margin 42%
- ROE 37%
Direction and relative strength of the recent share-price trend.
- 50-day MA above 200-day (golden cross zone)
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +21%
- Earnings in 20 days (strong beat history)
What Wall Street price targets and revisions are signalling.
Near-term events that could move the stock.
- Earnings in 20 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
How THC compares
As of October 13, 2026, Tenet Healthcare Corporation New ranks 1st of the 3 companies with a MELANY rating page in its SEC industry group (Services-General Medical & Surgical Hospitals, Nec), where the average score is 70.
Key risks for THC
- Trading near 52-week high, limited upside without new positive catalyst
Sector and theme context
Tenet Healthcare Corporation New sits in the Healthcare sector theme, which MELANY currently rates 53/100 for strength. Theme strength feeds THC's momentum and catalyst factors above.
THC trade plan (Pro)
MELANY has a full position plan for Tenet Healthcare Corporation New: a smart entry zone, an alert level, position sizing, and quarterly review triggers. It is part of Market Eyes Pro, and the first 30 days are free.
How MELANY rates THC
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. Tenet Healthcare Corporation New's 76/100 reflects mature factor weighting for its profile. Position framework managed by score-based check-ins, not a fixed holding period.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about THC
Is Tenet Healthcare Corporation New (THC) a buy?
As of 2026-10-09, MELANY rated Tenet Healthcare Corporation New Highest Conviction with a composite score of 76/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
What is Tenet Healthcare Corporation New's MELANY score?
Tenet Healthcare Corporation New (THC) has a MELANY composite score of 76/100, combining valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile, macro fit.
How is the THC stock rating calculated?
MELANY scores THC from 0 to 100 across eight weighted factors using live market and fundamental data, then refreshes the rating automatically as new data arrives.
Should I buy Tenet Healthcare Corporation New stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates Tenet Healthcare Corporation New (THC) Highest Conviction with a composite of 76/100 as of 2026-10-09. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the THC stock price forecast?
MELANY does not publish price targets or forecasts for THC. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 76/100 across eight factors for Tenet Healthcare Corporation New, and re-scores automatically as new price, earnings, and fundamental data arrive.
Is THC stock overvalued or undervalued?
MELANY's valuation factor currently reads 72/100 for Tenet Healthcare Corporation New, where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives THC's read.
What price should I buy THC at?
Rather than chasing the current price, MELANY computes a smart entry zone for THC: the price area where risk and reward actually favor a new position, plus an alert level and position sizing. The exact levels are part of Market Eyes Pro, which starts with a 30-day free trial.
What are the risks of buying THC stock?
The top risks MELANY currently flags for Tenet Healthcare Corporation New: Trading near 52-week high, limited upside without new positive catalyst. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is Tenet Healthcare Corporation New a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 64/100 for Tenet Healthcare Corporation New, and earnings track record, at 92/100. The 76/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will THC stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 72/100 for THC right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this THC rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-09. The price shown updates live, but the score is not recomputed on this page. MELANY re-scores THC continuously as new price, earnings, and fundamental data arrive, and the current rating is in the app (Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, THC included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.